Variant report
Variant | rs267772 |
---|---|
Chromosome Location | chr5:36066230-36066231 |
allele | C/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:36061400-36071000 | Weak transcription | Dnd41 | blood |
2 | chr5:36065000-36067400 | Flanking Active TSS | Fetal Thymus | thymus |
3 | chr5:36065800-36066400 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:36065800-36067200 | Active TSS | H1 Cell Line | embryonic stem cell |
5 | chr5:36066000-36066400 | Flanking Active TSS | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr5:36066000-36067200 | Active TSS | HUES64 Cell Line | embryonic stem cell |
7 | chr5:36066000-36067400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:36066000-36067400 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr5:36066200-36066400 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
10 | chr5:36066200-36066400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr5:36066200-36066400 | Flanking Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr5:36066200-36066400 | Flanking Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr5:36066200-36066400 | Flanking Bivalent TSS/Enh | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:36066200-36066400 | Flanking Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr5:36066200-36066400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
16 | chr5:36066200-36066400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
17 | chr5:36066200-36066600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr5:36066200-36066600 | Bivalent Enhancer | Brain Germinal Matrix | brain |
19 | chr5:36066200-36066600 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
20 | chr5:36066200-36066600 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |
21 | chr5:36066200-36066600 | Active TSS | Thymus | Thymus |
22 | chr5:36066200-36066800 | Bivalent Enhancer | Breast Myoepithelial Primary Cells | Breast |
23 | chr5:36066200-36067000 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr5:36066200-36067000 | Bivalent/Poised TSS | Fetal Intestine Small | intestine |
25 | chr5:36066200-36067000 | Enhancers | Pancreas | Pancrea |
26 | chr5:36066200-36067200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
27 | chr5:36066200-36067200 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
28 | chr5:36066200-36067200 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
29 | chr5:36066200-36067200 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
30 | chr5:36066200-36067200 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
31 | chr5:36066200-36067200 | Flanking Bivalent TSS/Enh | Foreskin Keratinocyte Primary Cells skin02 | Skin |
32 | chr5:36066200-36067200 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
33 | chr5:36066200-36067200 | Bivalent/Poised TSS | Fetal Kidney | kidney |
34 | chr5:36066200-36067200 | Enhancers | Spleen | Spleen |
35 | chr5:36066200-36067400 | Active TSS | H9 Cell Line | embryonic stem cell |
36 | chr5:36066200-36067400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
37 | chr5:36066200-36067400 | Bivalent/Poised TSS | Primary T cells from cord blood | blood |
38 | chr5:36066200-36067600 | Flanking Bivalent TSS/Enh | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
39 | chr5:36066200-36067600 | Enhancers | Fetal Heart | heart |